BACKGROUND: Isolated local relapse occurs in 24% to 35% of patients after definitive
chemoradiation for locally advanced non-small cell lung cancer. Although originally …

Following definitive chemoradiation therapy, 24%-35% of patients with locally advanced non–
small cell lung cancer have recurrence. We aimed to evaluate the feasibility of salvage …

Background Patients with locally advanced, non-small cell lung cancer treated with definitive
chemoradiotherapy alone often demonstrate persistent or recurrent disease. In the absence …

OBJECTIVES For highly selected patients with Stage III non-small-cell lung cancer (NSCLC)
who relapse or have residual disease after definitive chemoradiotherapy, salvage lung …

PURPOSE After surgical resection of non-small cell lung cancer, local/regional recurrence is
observed in 20% to 50% of patients, often without evidence of distant metastases. This …

Objectives Curative intent treatment options for locoregional recurrence or persistent tumor
after radical chemoradiotherapy for locally-advanced non-small cell lung cancer (NSCLC) …

Definitive chemoradiotherapy (CRT) has been a standard of care for patients with
unresectable stage III non-small cell lung cancer (NSCLC). However, locoregional …

Background The aim of this study was to describe the characteristics and outcomes of
patients with non-small cell lung cancer undergoing salvage surgery after …

Introduction Despite all treatment advances, lung cancer is still the main cause of death
worldwide. Treatment for resectable stage IIIA remains controversial including definitive …

OBJECTIVES The benefits of salvage resection for lung cancer recurrence following high-
dose curative-intent chemoradiation therapy are unclear. We assessed survival after …